Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Paola Bagella,1 Nicola Squillace,2 Elena Ricci,3 Roberto Gulminetti,4 Giuseppe Vittorio De Socio,5 Lucia Taramasso,6 Giovanni Pellicanò,7 Barbara Menzaghi,8 Benedetto Maurizio Celesia,9 Chiara Dentone,10 Giancarlo Orofino,11 Paolo Bonfanti,12 Giordano Madeddu13On behalf of the C.I.S.A.I....

Full description

Bibliographic Details
Main Authors: Bagella P, Squillace N, Ricci E, Gulminetti R, De Socio GV, Taramasso L, Pellicanò G, Menzaghi B, Celesia BM, Dentone C, Orofino G, Bonfanti P, Madeddu G
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Infection and Drug Resistance
Subjects:
HIV-1 infection
dolutegravir/abacavir/lamivudine
lipid profile
Online Access:https://www.dovepress.com/lipid-profile-improvement-in-virologically-suppressed-hiv-1-infected-p-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/lipid-profile-improvement-in-virologically-suppressed-hiv-1-infected-p-peer-reviewed-article-IDR

Similar Items